Green Lifescience has been growing earnings at an average annual rate of 2%, while the Life Sciences industry saw earnings declining at 3.1% annually. Revenues have been growing at an average rate of 5.4% per year. Green Lifescience's return on equity is 7.5%, and it has net margins of 5.9%.
How Green Lifescience makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A114450 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
51,017
3,011
1,876
217
31 Dec 25
40,340
110
1,841
292
30 Sep 25
34,656
-366
1,748
686
30 Jun 25
27,756
-1,953
1,618
709
31 Mar 25
23,191
-642
1,727
711
31 Dec 24
24,861
1,562
1,721
735
30 Sep 24
21,587
-12,664
1,979
359
30 Jun 24
24,604
-12,040
1,994
303
31 Mar 24
24,993
-14,416
2,205
221
31 Dec 23
22,369
-16,358
2,046
112
30 Sep 23
23,129
-5,177
1,918
114
30 Jun 23
22,314
-5,058
1,965
201
31 Mar 23
25,900
-4,513
1,569
427
31 Dec 22
36,505
-3,526
1,992
426
30 Sep 22
39,978
-2,267
2,136
461
30 Jun 22
39,758
-2,696
2,210
348
31 Mar 22
34,441
-2,524
2,361
110
31 Dec 21
25,338
-3,136
2,102
110
30 Sep 21
22,361
-2,615
1,734
0
30 Jun 21
21,203
-1,928
1,755
0
31 Mar 21
24,440
-854
1,706
0
31 Dec 20
24,561
-1,059
1,699
0
30 Sep 20
28,036
-8
1,953
0
30 Jun 20
31,875
428
1,834
0
31 Mar 20
33,657
140
1,919
0
31 Dec 19
37,618
1,196
2,204
0
30 Sep 19
34,305
-601
2,095
0
30 Jun 19
34,030
-815
2,167
0
31 Mar 19
31,294
-1,551
2,181
0
31 Dec 18
32,754
-1,445
1,996
0
30 Sep 18
36,947
-607
2,119
0
30 Jun 18
39,978
433
2,230
0
31 Mar 18
42,115
953
2,317
0
31 Dec 17
42,585
2,225
2,209
0
30 Sep 17
41,665
4,081
2,110
0
30 Jun 17
43,515
4,408
2,053
0
31 Mar 17
46,117
5,239
2,237
0
31 Dec 16
43,304
4,504
2,307
0
30 Sep 16
46,740
5,882
2,341
0
30 Jun 16
46,153
5,667
2,451
0
31 Mar 16
46,219
5,661
2,234
0
31 Dec 15
45,508
5,387
2,211
0
30 Sep 15
43,593
2,262
2,091
0
Quality Earnings: A114450 has a high level of non-cash earnings.
Growing Profit Margin: A114450 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A114450 has become profitable over the past 5 years, growing earnings by 2% per year.
Accelerating Growth: A114450 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A114450 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Life Sciences industry (-26.7%).
Return on Equity
High ROE: A114450's Return on Equity (7.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/24 20:17
End of Day Share Price
2026/07/24 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Green Lifescience Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.